Rare hereditary metabolic disease with peripheral neuropathy

Rare hereditary metabolic disease with peripheral neuropathy (Orphanet code 207018) is a broad classification category within Orphanet that encompasses a group of inherited metabolic disorders in which peripheral neuropathy — damage to the nerves outside the brain and spinal cord — is a prominent clinical feature. These conditions arise from inborn errors of metabolism that lead to the accumulation of toxic substances or deficiency of essential metabolites, ultimately causing nerve damage. The peripheral nervous system is particularly vulnerable in many metabolic diseases due to the high energy demands and specialized lipid composition of nerve fibers. This grouping includes a heterogeneous collection of disorders such as certain porphyrias, Fabry disease, Tangier disease, Refsum disease, metachromatic leukodystrophy, adrenomyeloneuropathy, and various mitochondrial disorders, among others. Symptoms commonly shared across these conditions include numbness, tingling, burning pain, muscle weakness, and loss of reflexes in the extremities. Depending on the specific underlying disorder, additional body systems may be affected, including the central nervous system, liver, kidneys, heart, skin, and eyes. Treatment varies widely depending on the specific metabolic disorder identified. Some conditions have targeted therapies available, such as enzyme replacement therapy (e.g., for Fabry disease), substrate reduction therapy, dietary modifications (e.g., phytanic acid restriction in Refsum disease), or heme therapy for acute porphyrias. For many of these disorders, management remains largely supportive, focusing on pain control, physical therapy, and monitoring for systemic complications. Early diagnosis through metabolic screening and genetic testing is critical, as timely intervention can slow disease progression in several of these conditions.

Common questions about Rare hereditary metabolic disease with peripheral neuropathy